Renal Failure in Trisomy 18: Mechanisms and Clinical Implications
Patients with Trisomy 18 develop renal failure primarily through congenital structural kidney malformations that are present from birth, including horseshoe kidney, polycystic kidneys, hydronephrosis, and renal dysplasia, which progressively impair kidney function over time.
Pathophysiology of Renal Complications
The renal abnormalities in Trisomy 18 arise from the presence of three copies of chromosome 18, which disrupts normal embryologic kidney development. These structural anomalies include:
- Horseshoe kidney (fusion of lower kidney poles)
- Polycystic kidney disease (multiple fluid-filled cysts replacing functional tissue)
- Hydronephrosis (obstruction causing kidney swelling)
- Renal dysplasia (abnormal kidney tissue development)
- Duplicated collecting systems (anatomic variants predisposing to obstruction)
These malformations reduce functional nephron mass from birth and create anatomic conditions that predispose to:
- Obstructive uropathy → progressive hydronephrosis → parenchymal damage
- Recurrent urinary tract infections → chronic pyelonephritis → scarring and nephron loss
- Inadequate filtration capacity → gradual decline in glomerular filtration rate
1 emphasizes that genitourinary complications significantly impact quality of life in survivors, requiring systematic monitoring.
Clinical Progression
The progression to renal failure is typically gradual rather than acute, occurring through:
- Congenital reduction in nephron number limits baseline kidney reserve
- Recurrent UTIs (common due to anatomic abnormalities and potential vesicoureteral reflux) cause cumulative damage
- Obstructive complications from structural anomalies lead to progressive hydronephrosis
- Growth failure and feeding difficulties (nearly universal in T18) compound metabolic stress on already compromised kidneys
2 notes that kidney anomalies are among the most frequent major malformations in Trisomy 18, alongside cardiac defects.
Surveillance Approach
For children with Trisomy 18 who survive beyond infancy, systematic renal monitoring is essential 1:
- Baseline renal ultrasound at diagnosis to identify structural anomalies
- Serial renal function testing (creatinine, BUN, urinalysis) every 3-6 months in the first year, then annually if stable
- Blood pressure monitoring at every visit (hypertension may indicate progressive renal disease)
- Prompt evaluation of any UTI symptoms with urine culture and consideration of imaging
- Voiding cystourethrogram (VCUG) if recurrent UTIs occur to assess for vesicoureteral reflux
Critical Clinical Pitfalls
Do not assume renal failure is inevitable or untreatable. 3 The 2025 AAP guidelines explicitly state that medical interventions should not be withheld based solely on the Trisomy 18 diagnosis. Treatable causes of renal deterioration include:
- Obstructive uropathy amenable to surgical correction
- UTIs requiring antibiotic prophylaxis
- Vesicoureteral reflux potentially correctable with surgery
Avoid delayed recognition of renal complications. The focus on cardiac and respiratory issues in T18 can overshadow progressive renal disease. Regular screening allows early intervention before irreversible damage occurs.
Management Considerations
When renal failure develops, treatment decisions should follow the same ethical framework as for other children 3:
- Dialysis and renal replacement therapy are not categorically excluded by the T18 diagnosis alone
- Decision-making should be individualized based on the child's overall clinical context, family goals of care, and whether interventions can achieve meaningful outcomes
- Palliative care involvement is appropriate when renal failure becomes progressive and treatment goals shift toward comfort 4
The increasing survival of children with Trisomy 18 beyond infancy 5 (with mortality decreasing from 32% in 1997 to 21% in 2016) means more children will live long enough to develop complications from congenital renal anomalies, making systematic surveillance increasingly important.